Increased serum PCSK9 concentrations are associated with periodontal infection but do not correlate with LDL cholesterol concentration

被引:30
作者
Miyazawa, Haruna [1 ,2 ]
Honda, Tomoyuki [1 ,2 ]
Miyauchi, Sayuri [1 ,2 ]
Domon, Hisanori [1 ]
Okui, Takafumi [1 ,2 ]
Nakajima, Takako [1 ,3 ]
Tabeta, Koichi [1 ]
Yamazaki, Kazuhisa [1 ,2 ]
机构
[1] Niigata Univ, Ctr Transdisciplinary Res, Chuo Ku, Niigata 9518514, Japan
[2] Niigata Univ, Lab Periodontol & Immunol, Div Oral Sci Hlth Promot, Grad Sch Med & Dent Sci,Chuo Ku, Niigata 9518514, Japan
[3] Niigata Univ, Gen Dent & Clin Educ Unit, Med & Dent Hosp, Chuo Ku, Niigata 9518514, Japan
基金
日本学术振兴会;
关键词
PCSK9; LDL cholesterol; Periodontitis; Chronic inflammation; CORONARY-HEART-DISEASE; LIPOPROTEIN RECEPTOR GENE; INFLAMMATORY MARKERS; PROTEIN; HYPERCHOLESTEROLEMIA; ATHEROSCLEROSIS; TRANSCRIPTION; MECHANISMS; CELLS; RISK;
D O I
10.1016/j.cca.2011.09.023
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Periodontal disease increases the risk of atherothrombotic disease, and high concentrations of low density lipoprotein (LDL) cholesterol are considered to be involved: however, the underlying mechanisms are largely unknown. Recent studies demonstrated that proprotein convertase subtilisin/kexin type 9 (PCSK9) plays a critical role in circulating LDL cholesterol concentrations. The aim of the present study is to analyze serum PCSK9 concentrations and their relation to lipoprotein concentrations in periodontitis patients. Methods: Sera were obtained from 40 periodontitis patients and 30 control subjects. PCSK9 concentrations, high-sensitivity C-reactive protein (hs-CRP), IL-6, TNF-alpha and Porphyromonas gingivalis antibodies were measured by ELISA, and lipid profiles were determined by a commercial laboratory. Results: Periodontitis patients demonstrated significantly higher serum antibody titer to P. gingivalis and hs-CRP concentrations than control subjects, suggesting infection with P. gingivalis and a systemic inflammatory response. PCSK9 concentrations in periodontitis patients were significantly higher than those in control subjects. However, the concentrations of total and LDL cholesterols were not significantly different between periodontitis patients and control subjects. Moreover, no correlations were observed between PCSK9 concentrations and lipid profiles. Conclusion: Periodontal infection upregulates PCSK9 production. However, further studies are required to elucidate how periodontal infection affects PCSK9 concentrations and subsequent lipid metabolism. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:154 / 159
页数:6
相关论文
共 50 条
  • [41] The role of PCSK9 in heart failure and other cardiovascular diseases-mechanisms of action beyond its effect on LDL cholesterol
    Dutka, Mieczyslaw
    Zimmer, Karolina
    Cwiertnia, Michal
    Ilczak, Tomasz
    Bobinski, Rafal
    HEART FAILURE REVIEWS, 2024, 29 (05) : 917 - 937
  • [42] PCSK9 genetic (rs11591147) and epigenetic (DNA methylation) modifications associated with PCSK9 expression and serum proteins in CAD patients
    Shyamala, Nivas
    Gundapaneni, Kishore Kumar
    Galimudi, Rajesh Kumar
    Tupurani, Mohini Aiyengar
    Padala, Chiranjeevi
    Puranam, Kaushik
    Kupsal, Keerthi
    Kummari, Ramanjaneyulu
    Gantala, Srilatha Reddy
    Nallamala, Krishna Reddy
    Sahu, Sanjib K.
    Hanumanth, Surekha Rani
    JOURNAL OF GENE MEDICINE, 2021, 23 (08)
  • [43] Increasing Serum Half-life and Extending Cholesterol Lowering in Vivo by Engineering Antibody with pH-sensitive Binding to PCSK9
    Chaparro-Riggers, Javier
    Liang, Hong
    DeVay, Rachel M.
    Bai, Lanfang
    Sutton, Janette E.
    Chen, Wei
    Geng, Tao
    Lindquist, Kevin
    Casas, Meritxell Galindo
    Boustany, Leila M.
    Brown, Colleen L.
    Chabot, Jeffrey
    Gomes, Bruce
    Garzone, Pamela
    Rossi, Andrea
    Strop, Pavel
    Shelton, Dave
    Pons, Jaume
    Rajpal, Arvind
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (14) : 11090 - 11097
  • [44] Chronic kidney disease on hemodialysis is associated with decreased serum PCSK9 levels
    Abujrad, H.
    Mayne, J.
    Ruzicka, M.
    Cousins, M.
    Raymond, A.
    Cheesman, J.
    Taljaard, M.
    Sorisky, A.
    Burns, K.
    Ooi, T. C.
    ATHEROSCLEROSIS, 2014, 233 (01) : 123 - 129
  • [45] Leptin and PCSK9 concentrations are associated with vascular endothelial cytokines in patients with stable coronary heart disease
    Wang, Qiang
    Zheng, Bo
    Chen, Peng
    Lei, Yan
    OPEN MEDICINE, 2022, 17 (01): : 185 - 190
  • [46] PCSK9 inhibition in LDL cholesterol reduction: Genetics and therapeutic implications of very low plasma lipoprotein levels
    Marais, A. David
    Kim, Jae B.
    Wasserman, Scott M.
    Lambert, Gilles
    PHARMACOLOGY & THERAPEUTICS, 2015, 145 : 58 - 66
  • [47] The rs13064411 polymorphism in the WDR52 gene, associated with PCSK9 levels, modifies statin-induced changes in serum total and LDL cholesterol levels
    de Keyser, Catherine E.
    Becker, Matthijs L.
    Hofman, Albert
    Lous, Jan J.
    Uitterlinden, Andre G.
    Visser, Loes E.
    Stricker, Bruno H.
    PHARMACOGENETICS AND GENOMICS, 2015, 25 (03) : 134 - 142
  • [48] PCSK9 SNP rs11591147 is associated with low cholesterol levels but not with cognitive performance or noncardiovascular clinical events in an elderly population
    Postmus, Iris
    Trompet, Stella
    de Craen, Anton J. M.
    Buckley, Brendan M.
    Ford, Ian
    Stott, David J.
    Sattar, Naveed
    Slagboom, P. Eline
    Westendorp, Rudi G. J.
    Jukema, J. Wouter
    JOURNAL OF LIPID RESEARCH, 2013, 54 (02) : 561 - 566
  • [49] SERUM sdLDL-C AND CELLULAR SREBP2-DEPENDENT CHOLESTEROL LEVELS; IS THERE A CHALLENGE ON TARGETING PCSK9?
    Soltanmohammadi, Elham
    Piran, Sadegh
    Mohammadi, Asghar
    Hosseni, Bita
    Naseri, Faezeh
    Shabani, Mohammad
    Najafi, Mohammad
    JOURNAL OF MEDICAL BIOCHEMISTRY, 2016, 35 (04) : 410 - 415
  • [50] Metformin enhances LDL-cholesterol uptake by suppressing the expression of the pro-protein convertase subtilisin/kexin type 9 (PCSK9) in liver cells
    Ali, Amjad
    Unnikannan, Hema
    Shafarin, Jasmin
    Bajbouj, Khuloud
    Taneera, Jalal
    Muhammad, Jibran Sualeh
    Hasan, Haydar
    Salehi, Albert
    Awadallah, Samir
    Hamad, Mawieh
    ENDOCRINE, 2022, 76 (03) : 543 - 557